Skip to main content
Log in

Gastrointestinal Stromal Tumors After Laparoscopic Gastric Bypass for Morbid Obesity: a Diagnostic and Therapeutic Challenge

  • Letter to the Editor
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Parab TM, DeRogatis MJ, Boaz AM, et al. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019;10(1):144–54.

    Article  Google Scholar 

  2. Belfiori G, Sartelli M, Cardinali L, et al. Risk stratification systems for surgically treated localized primary gastrointestinal stromal tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen. Ann Ital Chir. 2015;86(3):219–27.

    PubMed  Google Scholar 

  3. Iwatsuki M, Harada K, Iwagami S, et al. Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors. Ann Gastroenterol Surg. 2018;3(1):43–9.

    Article  Google Scholar 

  4. Kang JH, Le QA. Effectiveness of bariatric surgical procedures: a systematic review and network meta-analysis of randomized controlled trials. Medicine (Baltimore). 2017;96(46):e8632.

    Google Scholar 

  5. Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report. J Clin Gastroenterol. 1991;13:191–4.

    Article  CAS  Google Scholar 

  6. Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3:644–7.

    Article  Google Scholar 

  7. Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67:580–2.

    Article  CAS  Google Scholar 

  8. Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass. a case report. Curr Surg. 2003;60:521–3.

    PubMed  Google Scholar 

  9. Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16:932–4.

    Article  Google Scholar 

  10. Harper JL, Beech DS, Tichansky S, et al. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17:1268–71.

    Article  Google Scholar 

  11. Abellán I, Ruíz de Angulo D, Parrilla P. Incidental gastric gastrointestinal stromal tumor (GIST) in the excluded stomach after Roux-en-Y gastric bypass: a case report and review of the literature. Surg Obes Relat Dis. 2014 Jan-Feb;10(1):e13–4.

    Article  Google Scholar 

  12. Menéndez P, Padilla D, Villarejo P, et al. Does bariatric surgery decrease gastric cancer risk? Hepatogastroenterology. 2012;59:409–12.

    PubMed  Google Scholar 

  13. Chiappetta S, Theodoridou S, Stier C, et al. Incidental finding of GIST during obesity surgery. Obes Surg. 2015;25(3):579–83.

    Article  Google Scholar 

  14. Yuval JB, Khalaileh A, Abu-Gazala M, et al. The true incidence of gastric GIST-a study based on morbidly obese patients undergoing sleeve gastrectomy. Obes Surg. 2014;24(12):2134–7.

    Article  Google Scholar 

  15. Beltran MA, Pujado B, Méndez PE, et al. Gastric gastrointestinal stromal tumor (GIST) incidentally found and resected during laparoscopic sleeve gastrectomy. Obes Surg. 2010;20(3):393–6.

    Article  Google Scholar 

  16. Wang Y, Liu J. Laparoscopic sleeve gastrectomy in the treatment of gastrointestinal stroma tumours in morbid obese patients. BMJ Case Rep. 2009;2009

  17. Sanchez BR, Morton JM, Curet MJ, et al. Incidental finding of gastrointestinal stromal tumors (GISTs) during laparoscopic gastric bypass. Obes Surg. 2005;15(10):1384–8.

    Article  Google Scholar 

  18. Søreide K, Sandvik OM, Søreide JA, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46.

    Article  Google Scholar 

  19. Sandvik OM, Søreide K, Kvaløy JT, et al. Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades. Cancer Epidemiol. 2011;35(6):515–20.

    Article  Google Scholar 

  20. Praveenraj P, Gomes RM, Kumar S, et al. Diagnostic yield and clinical implications of preoperative upper gastrointestinal endoscopy in morbidly obese patients undergoing bariatric surgery. J Laparoendosc Adv Surg Tech A. 2015;25(6):465–9.

    Article  Google Scholar 

  21. Schneider R, Lazaridis I, Kraljević M, et al. The impact of preoperative investigations on the management of bariatric patients; results of a cohort of more than 1200 cases. Surg Obes Relat Dis. 2018;14(5):693–9.

    Article  Google Scholar 

  22. Schigt A, Coblijn U, Lagarde S, et al. Is esophagogastroduodenoscopy before Roux-en-Y gastric bypass or sleeve gastrectomy mandatory? Surg Obes Relat Dis. 2014;10(3):411–7.

    Article  Google Scholar 

  23. Saarinen T, Kettunen U, Pietiläinen KH, et al. Is preoperative gastroscopy necessary before sleeve gastrectomy and Roux-en-Y gastric bypass? Surg Obes Relat Dis. 2018 Jun;14(6):757–62.

    Article  Google Scholar 

  24. Salama A, Saafan T, El Ansari W, et al. Is routine preoperative esophagogastroduodenoscopy screening necessary prior to laparoscopic sleeve gastrectomy? Review of 1555 cases and comparison with current literature. Obes Surg. 2018;28(1):52–60.

    Article  Google Scholar 

  25. Yoo C, Ryu MH, Kang BW, et al. Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib. J Clin Oncol. 2010;28(9):1554–9.

    Article  CAS  Google Scholar 

  26. Demetri GD, Wang Y, Wehrle E, et al. Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors. J Clin Oncol. 2009;27(19):3141–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. A. Fernández.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Declaration of Ethical Approval

All the procedures carried out in studies with human participants were in accordance with the ethical standards of the institutional and/or national research committee and the Declaration of Helsinki of 1964 and its subsequent modifications or comparable ethical standards.

Declaration of Informed Consent

The informed consent was obtained from all the individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernández, J.A., Frutos, M.D., Ruiz-Manzanera, J.J. et al. Gastrointestinal Stromal Tumors After Laparoscopic Gastric Bypass for Morbid Obesity: a Diagnostic and Therapeutic Challenge. OBES SURG 29, 2618–2621 (2019). https://doi.org/10.1007/s11695-019-03944-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-019-03944-y

Navigation